IFP Advisors’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-37
Closed -$2.1K 3094
2019
Q4
$3K Buy
+37
New +$2.68K ﹤0.01% 2433
2019
Q1
$18K Sell
275
-38
-12% -$2.88K ﹤0.01% 1398
2018
Q4
$23K Sell
313
-19
-6% -$1.57K ﹤0.01% 2060
2018
Q3
$31K Sell
332
-293
-47% -$27.9K ﹤0.01% 2197
2018
Q2
$61K Buy
625
+568
+996% +$63.5K ﹤0.01% 1801
2018
Q1
$6K Hold
57
﹤0.01% 3116
2017
Q4
$6K Hold
57
﹤0.01% 3163
2017
Q3
$5K Hold
57
﹤0.01% 3435
2017
Q2
$4K Hold
57
﹤0.01% 3559
2017
Q1
$5K Sell
57
-120
-68% -$9.54K ﹤0.01% 3349
2016
Q4
$14K Sell
177
-20
-10% -$1.55K ﹤0.01% 2722
2016
Q3
$15K Buy
197
+40
+25% +$2.9K ﹤0.01% 2610
2016
Q2
$11K Sell
157
-118
-43% -$8.14K ﹤0.01% 2710
2016
Q1
$18K Buy
275
+118
+75% +$7.41K ﹤0.01% 1396
2015
Q4
$10K Buy
+157
New +$9.58K ﹤0.01% 2603

Other funds holding CMD

IFP Advisors's CMD Position: Q1 2020 in Review

IFP Advisors sold out of Cantel Medical Corporation (CMD) in Q1 2020, closing a stake of 37 shares — an estimated $2.1K sold.

IFP Advisors first reported a position in CMD in Q4 2015 and held it in 15 quarters. The position peaked at $61K in Q2 2018. 213 funds tracked by Wall St. Rank hold CMD as of Q1 2020.

  • IFP Advisors reported no remaining Cantel Medical Corporation position as of Q1 2020 after selling out during the quarter.
  • IFP Advisors sold 37 Cantel Medical Corporation shares in Q1 2020, an estimated $2.1K.
  • IFP Advisors first reported a position in Cantel Medical Corporation in Q4 2015 and held it in 15 quarters.
  • IFP Advisors's Cantel Medical Corporation position peaked at $61K in Q2 2018.
  • 213 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2020.

Based on IFP Advisors's 13F filing for Q1 2020, filed 12 May 2020.